Aug. 18, 2022
by Bohdana Sokolova
Biopharma insight
Development of a novel drug is a tedious process that requires immense investments of resources and time - on average, …
Aug. 17, 2022
by Andrii Buvailo
Interview
Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase …
Aug. 11, 2022
by Natalia Honchar
Biopharma insight
Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. …
Aug. 10, 2022
by Andrii Buvailo
Biopharma insight
Today, Insilico Medicine, a leading player in artificial intelligence (AI)-driven drug discovery and longevity research, tops up its recent $60 …
Aug. 1, 2022
by Natalia Honchar
Biopharma insight
Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform …
July 28, 2022
by Natalia Honchar
Biopharma insight
Valo Therapeutics Oy (ValoTx), the developer of antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious …
July 26, 2022
by Andrii Buvailo, Bohdana Sokolova
Biopharma insight
(Last updated: 27/07/2022) -- for sponsorships and media partnerships, reach out at info@biopharmatrend.com Artificial intelligence (machine learning and deep learning, …
July 19, 2022
by Natalia Honchar, Andrii Buvailo
Biopharma insight
Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet …
July 18, 2022
by Joseph Pareti
Biopharma insight
The motivation for this report In 2018, while at Supercomputing in Dallas I had a couple key encounters that profoundly …
July 12, 2022
by Natalia Honchar
News
Receptor.AI, a UK-based start-up company which integrates artificial intelligence (AI) into drug discovery, just announced the public launch of the …
July 11, 2022
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
July 8, 2022
by Natalia Honchar
News
Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
July 4, 2022
by Andrii Buvailo
Biopharma insight
The terms “big data”, “machine learning” and “artificial intelligence” have been trending in the drug discovery space for several years, …
June 17, 2022
by Andrii Buvailo
Biopharma insight
While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving …
May 30, 2022
by Andrii Buvailo
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …
May 17, 2022
by Andrii Buvailo
Biopharma insight
Artificial intelligence (AI) is undoubtedly a big deal in the pharmaceutical industry, bringing the unprecedented abilities of modeling biology at …
May 6, 2022
by Bohdana Sokolova, Andrii Buvailo
Biopharma insight
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
May 4, 2022
by Bohdana Sokolova
Undefined
Ever since the early 2000s, Artificial Intelligence (AI) has become a useful tool in various fields, from game design and …
May 3, 2022
by Andrii Buvailo
Interview
The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number …